Gastric adenocarcinoma with chief cell differentiation

Pathology International

Volumn 57, Issue 8, 2007, Pages 517-522

  Tsukamoto, Tetsuya ^a   Yokoi, Takio ^a   Maruta, Shinya ^b   Kitamura, Masakazu ^b   Yamamoto, Tsuyoshi ^b   Ban, Hisayo ^a   Tatematsu, Masae ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b Tokai Hospital   (Japan)

Author keywords

Chief cell; Human stomach; MUC6; Mucous neck cell; Pepsinogen I; Pepsinogen II; Primitive chief cell; RUNX3

Indexed keywords

DEFENSIN; MUCIN 6; PEPSINOGEN I; PEPSINOGEN II; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR RUNX3;

AGED; ARTICLE; BASOPHIL; CANCER DIAGNOSIS; CANCER SIZE; CANCER SURGERY; CARDIA; CASE REPORT; CELL DIFFERENTIATION; CELL TYPE; COLUMNAR EPITHELIUM; FEMALE; GASTRECTOMY; GASTROINTESTINAL ENDOSCOPY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUS; IMMUNOHISTOCHEMISTRY; MUCOUS CELL; PHENOTYPE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CHIEF CELL;

ADENOCARCINOMA; AGED, 80 AND OVER; CARDIA; CHIEF CELLS, GASTRIC; FEMALE; HUMANS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34447106268     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2007.02134.x     Document Type: Article

References (32)

1. Tatematsu M, Tsukamoto T, Inada K. Stem cells and gastric cancer: Role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 2003 94 : 135 41.
2. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma: An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965 64 : 31 49.
3. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: Its histogenesis and histological appearances. Gann 1968 59 : 251 8.
4. Sugano H, Nakamura K, Kato Y. Pathological studies of human gastric cancer. Acta Pathol Jpn 1982 32 : 329 47.
5. Tatematsu M, Furihata C, Katsuyama T et al. Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure. Cancer Res 1986 46 : 4866 72.
6. Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990 40 : 494 504.
7. Mizoshita T, Inada K, Tsukamoto T et al. Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa: With special emphasis on participation in intestinal metaplasia of the human stomach. Gastric Cancer 2001 4 : 185 91.
8. Mizoshita T, Inada K, Tsukamoto T et al. Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. J Cancer Res Clin Oncol 2004 130 : 29 36.
9. Mizoshita T, Tsukamoto T, Inada K et al. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol Int 2004 54 : 392 400.
10. Mizoshita T, Tsukamoto T, Nakanishi H et al. Expression of Cdx2 and the phenotype of advanced gastric cancers: Relationship with prognosis. J Cancer Res Clin Oncol 2003 129 : 727 34.
11. Mizoshita T, Tsukamoto T, Tanaka H et al. Colonic and small-intestinal phenotypes in gastric cancers: Relationships with clinicopathological findings. Pathol Int 2005 55 : 611 18.
12. Inada KI, Mizoshita T, Tsukamoto T, Porter EM, Tatematsu M. Paneth type gastric cancer cells exhibit expression of human defensin-5. Histopathology 2005 47 : 330 31.
13. Li XL, Eishi Y, Bai YQ et al. Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J Oncol 2004 24 : 257 63.
14. Tsukamoto T, Mizoshita T, Mihara M et al. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology 2005 46 : 649 58.
15. Sakai H, Eishi Y, Li XL et al. PDX1 homeobox protein expression in pseudopyloric glands and gastric carcinomas. Gut 2004 53 : 323 30.
16. Capella C, Frigerio B, Cornaggia M, Solcia E, Pinzon-Trujillo Y, Chejfec G. Gastric parietal cell carcinoma - newly recognized entity: Light microscopic and ultrastructural features. Histopathology 1984 8 : 813 24.
17. Takubo K, Honma N, Sawabe M et al. Oncocytic adenocarcinoma of the stomach: Parietal cell carcinoma. Am J Surg Pathol 2002 26 : 458 65.
18. Tsukamoto T, Inada K, Tanaka H et al. Down regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: Inverse correlation during progression from gastric/intestinal- mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol 2004 130 : 135 45.
19. Gritti I, Banfi G, Roi GS. Pepsinogens: Physiology, pharmacology pathophysiology and exercise. Pharmacol Res 2000 41 : 265 81.
20. Takahashi K. Gene structures of pepsinogens A and C. Scand J Clin Lab Invest Suppl 1992 210 : 97 110.
21. Stemmermann GN, Samloff IM, Hayashi T. Pepsinogens I and II in carcinoma of the stomach: An immunohistochemical study. Appl Pathol 1985 3 : 159 63.
22. Huang SC, Miki K, Sano J et al. Pepsinogens I and II in gastric cancer: An immunohistochemical study using monoclonal antibodies. Jpn J Cancer Res 1988 79 : 1139 46.
23. Li QL, Ito K, Sakakura C et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002 109 : 113 24.
24. Osaki M, Moriyama M, Adachi K et al. Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma. Eur J Clin Invest 2004 34 : 605 12.
25. Sakakura C, Hagiwara A, Miyagawa K et al. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Int J Cancer 2005 113 : 221 8.
26. Ito K, Liu Q, Salto-Tellez M et al. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 2005 65 : 7743 50.
27. Ho SB, Roberton AM, Shekels LL, Lyftogt CT, Niehans GA, Toribara NW. Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression. Gastroenterology 1995 109 : 735 47.
28. Suzuki S, Tsuyama S, Murata F. Cells intermediate between mucous neck cells and chief cells in rat stomach. Cell Tissue Res 1983 233 : 475 84.
29. Kataoka K, Takeoka Y, Furihata C. Immunocytochemical study of pepsinogen 1-producing cells in the fundic mucosa of the stomach in developing mice. Cell Tissue Res 1990 261 : 211 17.
30. Kantani-Matsumoto A, Kataoka K. A carbohydrate histochemical study on surface mucous cells, mucous neck cells and chief cells in the gastric mucosa of developing mice. Arch Histol Cytol 1989 52 : 37 50.
31. Müller-Höcker J, Rellecke P. Chief cell proliferation of the gastric mucosa mimicking early gastric cancer: An unusual variant of fundic gland polyp. Virchows Arch 2003 442 : 496 500.
32. Matsukawa A, Kurano R, Takemoto T, Kagayama M, Ito T. Chief cell hyperplasia with structural and nuclear atypia: A variant of fundic gland polyp. Pathol Res Pract 2005 200 : 817 21.